Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2010 2
2012 1
2013 1
2015 1
2016 2
2017 3
2018 2
2019 4
2020 13
2021 8
2022 6
2023 11
2024 7
2025 4
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Primary central nervous system lymphoma.
Ferreri AJM, Calimeri T, Cwynarski K, Dietrich J, Grommes C, Hoang-Xuan K, Hu LS, Illerhaus G, Nayak L, Ponzoni M, Batchelor TT. Ferreri AJM, et al. Among authors: hu ls. Nat Rev Dis Primers. 2023 Jun 15;9(1):29. doi: 10.1038/s41572-023-00439-0. Nat Rev Dis Primers. 2023. PMID: 37322012 Free PMC article. Review.
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Barajas RF, Politi LS, Anzalone N, Schöder H, Fox CP, Boxerman JL, Kaufmann TJ, Quarles CC, Ellingson BM, Auer D, Andronesi OC, Ferreri AJM, Mrugala MM, Grommes C, Neuwelt EA, Ambady P, Rubenstein JL, Illerhaus G, Nagane M, Batchelor TT, Hu LS. Barajas RF, et al. Among authors: hu ls. Neuro Oncol. 2021 Jul 1;23(7):1056-1071. doi: 10.1093/neuonc/noab020. Neuro Oncol. 2021. PMID: 33560416 Free PMC article.
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.
Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY. Aizer AA, et al. Among authors: hu ls. Neuro Oncol. 2022 Oct 3;24(10):1613-1646. doi: 10.1093/neuonc/noac118. Neuro Oncol. 2022. PMID: 35762249 Free PMC article. Review.
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.
Sarkaria JN, Ballman KV, Kizilbash SH, Sulman EP, Giannini C, Friday BB, Butowski NA, Mohile NA, Piccioni DE, Battiste JD, Drappatz J, Campian JL, Mashru S, Jaeckle KA, O'Brien BJ, Dixon JG, Kabat BF, Laack NL, Hu LS, Kaufmann T, Kumthekar P, Ellingson BM, Anderson SK, Galanis E. Sarkaria JN, et al. Among authors: hu ls. JAMA Oncol. 2024 Dec 1;10(12):1637-1644. doi: 10.1001/jamaoncol.2024.4361. JAMA Oncol. 2024. PMID: 39480453 Free PMC article. Clinical Trial.
Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures.
Hu LS, D'Angelo F, Weiskittel TM, Caruso FP, Fortin Ensign SP, Blomquist MR, Flick MJ, Wang L, Sereduk CP, Meng-Lin K, De Leon G, Nespodzany A, Urcuyo JC, Gonzales AC, Curtin L, Lewis EM, Singleton KW, Dondlinger T, Anil A, Semmineh NB, Noviello T, Patel RA, Wang P, Wang J, Eschbacher JM, Hawkins-Daarud A, Jackson PR, Grunfeld IS, Elrod C, Mazza GL, McGee SC, Paulson L, Clark-Swanson K, Lassiter-Morris Y, Smith KA, Nakaji P, Bendok BR, Zimmerman RS, Krishna C, Patra DP, Patel NP, Lyons M, Neal M, Donev K, Mrugala MM, Porter AB, Beeman SC, Jensen TR, Schmainda KM, Zhou Y, Baxter LC, Plaisier CL, Li J, Li H, Lasorella A, Quarles CC, Swanson KR, Ceccarelli M, Iavarone A, Tran NL. Hu LS, et al. Nat Commun. 2023 Sep 28;14(1):6066. doi: 10.1038/s41467-023-41559-1. Nat Commun. 2023. PMID: 37770427 Free PMC article.
The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas.
Shiroishi MS, Erickson BJ, Hu LS, Barboriak DP, Becerra L, Bell LC, Boss MA, Boxerman JL, Cen S, Cimino L, Fan Z, Keenan KE, Kirsch JE, Ameli N, Nazemi S, Quarles CC, Rosen MA, Rodriguez L, Schmainda KM, Zahlmann G, Zhou Y, Obuchowski N, Wu O; RSNA QIBA Dynamic Susceptibility Contrast MRI Biomarker Committee. Shiroishi MS, et al. Among authors: hu ls. Radiology. 2024 Dec;313(3):e232555. doi: 10.1148/radiol.232555. Radiology. 2024. PMID: 39656118 Free PMC article. Review.
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patients.
Oh JH, Reed SK, Riviere-Cazaux C, Kim M, Mladek AC, Illamola SM, Zhang W, Vaubel RA, Caron A, Regan MS, Birnbaum AK, Mohammad A, Zhang W, Dixon JG, Kaufmann TJ, Hu LS, Ma DJ, Kizilbash S, Agar NYR, Giannini C, Geyer SM, Parney IF, Galanis E, Burns TC, Elmquist WF, Sarkaria JN. Oh JH, et al. Among authors: hu ls. Neuro Oncol. 2026 Jan 1;28(1):130-142. doi: 10.1093/neuonc/noaf204. Neuro Oncol. 2026. PMID: 40916832 Free PMC article.
Imaging of intratumoral heterogeneity in high-grade glioma.
Hu LS, Hawkins-Daarud A, Wang L, Li J, Swanson KR. Hu LS, et al. Cancer Lett. 2020 May 1;477:97-106. doi: 10.1016/j.canlet.2020.02.025. Epub 2020 Feb 27. Cancer Lett. 2020. PMID: 32112907 Free PMC article. Review.
The Alliance AMBUSH Trial: Rationale and Design.
Mahajan A, Shih H, Penas-Prado M, Ligon K, Aldape K, Hu LS, Loughan AR, Basso MR, Leeper HE, Nahed BV, Stott SL, Geyer S, Giannini C, Galanis E. Mahajan A, et al. Among authors: hu ls. Cancers (Basel). 2022 Jan 14;14(2):414. doi: 10.3390/cancers14020414. Cancers (Basel). 2022. PMID: 35053576 Free PMC article. Review.
66 results